| Name | Title | Contact Details |
|---|
American Business Development Corporation (ABD) helps B2B service providers build scalable, high-impact business development (BD) operations. We specialize in structuring BD strategies, aligning marketing and outreach efforts, and securing key partnerships to drive growth. Whether through a customized Business Development Plan®, implementing BD processes, or serving as an outsourced BD team, ABD ensures companies have the tools, strategy, and execution needed to expand their client pipeline and increase revenue. ABD was founded on the belief that business development is built on relationships, not automation. We dont rely on spam emails or impersonal outreach. Instead, we focus on strategic engagement, tailored messaging, and real human connections to generate high-quality leads and long-term partnerships. Our expertise spans industries such as life sciences, medical devices, professional services, and international trade, helping companies break into new markets and optimize BD functions. For companies expanding into the U.S. market, ABD provides outsourced BD solutions, acting as a dedicated U.S.-based BD team. We represent companies at key industry conferences, execute outreach on partnering platforms, conduct meetings, and manage post-conference follow-up—ensuring that warm, engaged leads are seamlessly transferred to the clients internal team. This eliminates costly international travel while maximizing business development opportunities. ABD also supports export strategies, helping companies expand into foreign markets through strategic partnerships, trade mission planning, and regulatory alignment. With over 20 years of international economic development experience, we connect businesses with high-value clients and funding opportunities through government agencies, accelerators, and industry leaders. At ABD, we dont just generate leads—we build long-term, sustainable BD operations that drive growth beyond our engagement.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
ADEC Innovations seamlessly delivers fully integrated, cost-effective industry expertise, business process & data management, and software services. Our mission: to ensure we meet your ever-evolving ESG needs and help you improve sustainability performance, gain unprecedented insights, optimize resource use, and drive operational efficiencies. With a global force of over 3,500 employees, our presence spans five continents – Asia, Australia, Europe, Africa and North America. We offer a wide range of solutions and consulting services across multiple fields, providing industry expertise in sustainability, environmental data services, knowledge management, data management, health information, and public-private partnerships. In all these business areas, we focus on aggregating, organizing and giving visibility to data in order to enable client organizations leaders and stakeholders to make informed decisions. Our comprehensive suite of ESG Solutions assist organizations in minimizing negative social and environmental impacts, maximize efficiency, and drive long-term business growth through sustainable profitability and empowered decision making.
Verdegard offers a complete suite of innovative, integrated, and concierge-level services. Plan designs include PPO options, reference-based, level funded, and hybrid plans which provide unique transparency, patient advocacy, and cost containment options to maximize the benefits and savings.